Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1995
05/18/1995WO1995013074A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
05/18/1995WO1995013073A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
05/18/1995WO1995013071A2 Treatment of immunoregulatory disorders
05/18/1995WO1995013067A1 Oxazoles for treating cytokine mediated diseases
05/18/1995WO1995013061A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
05/18/1995CA2176237A1 Treatment of bacterially-induced inflammatory diseases
05/18/1995CA2176013A1 Treatment of immunoregulatory disorders
05/18/1995CA2173731A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995CA2172809A1 Pyrimidine-thioalkyl and alkylether compounds
05/17/1995EP0653439A2 Stabilized oligonucleotids and the use thereof
05/17/1995EP0653436A1 5-Methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T)
05/17/1995EP0653425A1 1-(2-Fluorocyclopropyl)-quinolone- and naphthyridone carboxylic acid derivatives, their preparation and their use as antibacterials
05/17/1995EP0653207A1 Aids virus infection inhibitor composition
05/17/1995EP0652972A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure
05/17/1995EP0652966A1 Method of increasing expression of viral proteins
05/17/1995EP0652956A1 Cloning and expression of a protein antigen of toxoplasma gondii
05/17/1995EP0652899A1 A fungicidally active compound
05/17/1995EP0652895A1 Compounds which inhibit hiv replication
05/17/1995EP0652890A1 Oligonucleotide alkylphosphonothioates
05/17/1995EP0652888A1 INHIBITION OF $i(CANDIDA)
05/17/1995EP0652875A1 (hetero)-aryl ketones derivatives with antibacterial properties
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652776A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
05/17/1995EP0652772A1 Herpesvirus vaccines
05/17/1995EP0652771A1 Tetanus vaccine production
05/17/1995EP0652758A1 Diphtheria toxin vaccines
05/17/1995EP0652753A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam
05/17/1995EP0567582B1 Liposomal-polyene preliposomal powder and method for its preparation
05/17/1995EP0497816B1 Treatment of hiv infections and compounds useful therein
05/17/1995CN1028430C Process for preparing new derivatives of 1-dethia 2-thia cephalosporanic acids
05/17/1995CA2135548A1 Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid
05/16/1995US5416222 3-pyrrolidine methanamines wherein the alpha-carbon is substituted by 1 or 2 lower alkyl groups which are intermediates for pyridone-carboxylic acid derivatives
05/16/1995US5416209 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
05/16/1995US5416203 Steroid modified oligonucleotides
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416096 7-(1-pyrrolidinyl)-3-quinolone carboxylic acid derivatives as antibacterial agents and feed additives
05/16/1995US5416081 Cephalosporin compounds
05/16/1995US5416080 Cephalosporins
05/16/1995US5416021 Fibronectin binding protein-encoding DNA
05/16/1995US5415859 Production and use of antheimintic agents and protective antigens
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/16/1995CA1335571C Vaccine preparation comprising a bacterial toxin adjuvant
05/11/1995WO1995012682A2 Viral vector with bovine viral diarrhea virus (bvdv) antigens
05/11/1995WO1995012677A2 Immunodominant human t-cell epitopes of hepatitis c virus
05/11/1995WO1995012673A1 Receptor on the surface of activated t-cells: acts-4
05/11/1995WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/11/1995WO1995012410A1 Vaccine design and production
05/11/1995WO1995012405A1 Method and composition for treatment of patients having decompensated liver disease
05/11/1995WO1995012400A1 Novel enzyme inhibitors, their synthesis, and methods for use
05/11/1995WO1995012397A1 Plaster for treating nail mycoses
05/11/1995WO1995012396A1 Method for inhibiting intracellular viral replication
05/11/1995WO1995012393A1 Plaster for the treatment of nail mycoses
05/11/1995WO1995012308A1 Method of introducing material into eggs during early embryonic development
05/11/1995WO1995000638A3 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
05/11/1995CA2175708A1 Vaccine design and production
05/11/1995CA2175692A1 Immunodominant human t-cell epitopes of hepatitis c virus
05/11/1995CA2175186A1 Method of introducing material into eggs during early embryonic development
05/11/1995CA2172815A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens
05/11/1995CA2153146A1 Method for inhibiting intracellular viral replication
05/11/1995CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/10/1995EP0652287A2 Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease
05/10/1995EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/10/1995EP0652230A1 Biologically active bactericidal/permeability-increasing protein fragments
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652011A1 Prophylactic and remedy for viral diseases in respiratory tract
05/10/1995EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
05/10/1995EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
05/10/1995EP0651806A1 Anti-feline immunodeficiency virus (fiv) vaccines
05/10/1995EP0651805A1 Method of intracellular binding of target molecules
05/10/1995EP0651796A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena
05/10/1995EP0651790A1 Type-c rotavirus cultures and uses therefor
05/10/1995EP0651789A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
05/10/1995EP0651767A1 Biologically active polypeptides derived from an actinomycete
05/10/1995EP0651759A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
05/10/1995EP0651755A1 Cephalosporins and 1-carba-1-dethia cephalosporins
05/10/1995EP0651753A1 Pyridonecarboxylic acid derivatives and processes for preparing the same
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651654A1 Lysozyme dimer and compositions containing the same
05/10/1995EP0651649A1 Granulocyte colony-stimulating factor solution delivery method
05/10/1995EP0651646A1 Therapeutic conjugates of toxins and drugs
05/10/1995EP0651609A1 Pasteurella multocida toxoid vaccines
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/10/1995EP0366718B1 Monoclonal antibodies neutralizing hiv-1
05/10/1995EP0301078B1 Polypeptides with activity against gram-positive and gram-negative bacteria
05/10/1995EP0222842B1 Cloning and expression of host-protective immunogens of ibdv
05/10/1995CN1028368C Process for preparing nojirimycin derivatives
05/09/1995US5414096 Chemical intermediates; DNA viruses
05/09/1995US5414076 DNA encoding gibbon ape leukemia virus receptor
05/09/1995US5414073 Treatment with dimethylphosphoryl azide and hydrolysis
05/09/1995US5414000 Antiviral pyrinyl substituted tetrahydropyrans
05/09/1995US5413999 HIV protease inhibitors useful for the treatment of AIDS
05/09/1995US5413996 Targeted drug delivery via phosphonate derivatives
05/09/1995US5413991 Chitinase inhibitors; fungicides, insecticides
05/09/1995US5413777 Pulsatile once-a-day delivery systems for minocycline
05/07/1995WO1995012601A1 Crystalline penicillin derivative, and its production and use
05/04/1995WO1995011975A2 Retroviral superantigens, superantigen peptides, and methods of use
05/04/1995WO1995011919A2 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE
05/04/1995WO1995011905A1 2-(pyrazol-3-yl)carbapenem derivatives
1 ... 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 ... 1798